Post-exposure prophylaxis for Middle East respiratory syndrome in healthcare workers

The Journal of Hospital Infection
S Y ParkH Shi

Abstract

An effective post-exposure prophylaxis (PEP) strategy may limit the spread of infection. However, there is no consensus regarding PEP for Middle East respiratory syndrome coronavirus (MERS-CoV) infection. This study assessed the efficacy of ribavirin and lopinavir/ritonavir as PEP for healthcare workers (HCWs) exposed to patients with severe MERS-CoV pre-isolation pneumonia. The safety of the PEP regimen was assessed. HCWs with high-risk exposure to MERS-CoV pre-isolation pneumonia were retrospectively enrolled. HCWs who received PEP therapy were classified into the PEP group. PEP therapy was associated with a 40% decrease in the risk of infection. There were no severe adverse events during PEP therapy.

Citations

May 14, 2020·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Hyo-Lim HongHyun Hee Kwon
Jun 10, 2020·International Journal of Environmental Research and Public Health·Ivan GentileAnnamaria Colao
Jul 30, 2020·Clinical Pharmacokinetics·Markus ZeitlingerUNKNOWN PK/PD of Anti-Infectives Study Group (EPASG) of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID)
Aug 14, 2020·Human Vaccines & Immunotherapeutics·Mohamad Hesam ShahrajabianQi Cheng
May 26, 2020·Expert Opinion on Emerging Drugs·Yanyi TaoYu Hu
May 2, 2020·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Michael A CharyMichele M Burns
Oct 28, 2020·Expert Review of Vaccines·Rémi LabetoulleAmandine Gagneux-Brunon
Nov 5, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Giuseppe PattiUNKNOWN Italian Study Group on Atherosclerosis, Thrombosis, Vascular Biology
Nov 21, 2020·Journal of Clinical Pharmacology·Golbarg AlavianZahra Sadat Torabi
Nov 1, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Alfonso CabelloMiguel Górgolas
Dec 12, 2020·Journal of Electrocardiology·Julio Echarte-MoralesFelipe Fernández-Vázquez
Mar 18, 2021·Immune Network·Erica EspañoJeong-Ki Kim
Jun 1, 2020·The Lancet. HIV·Pilar VizcarraUNKNOWN COVID-19 ID Team
Mar 1, 2021·Clinical Pharmacology and Therapeutics·Silke GastineJoseph F Standing
May 4, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Devendra Kumar, Neerja Trivedi
Apr 28, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Monica ArduraUNKNOWN Transplant-Associated Learning Network Team (TALNT)
Jun 23, 2020·Indian Journal of Critical Care Medicine : Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine·Yatin MehtaSrinivas Samavedam
May 26, 2021·Journal of Medical Virology·Parisa S AghbashHossein B Baghi
Aug 28, 2021·Acta chirurgica Belgica·Julia Bernal TirapoE Ferrero Herrero

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay

Software Mentioned

SPSS
PASW

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
S A WangA Saah
Journal of the American Optometric Association
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Sasisopin KiertiburanakulKumthorn Malathum
© 2022 Meta ULC. All rights reserved